|
Biomarker
|
Non-AKI
|
Mild AKI
|
Severe AKI
|
P
|
|---|
|
(n = 123)
|
(n = 10)
|
(n = 11)
|
|---|
|
sFGF23, pg/mL
|
79.33 [49.88–115.84]
|
59.97 [50.25–81.57]
|
92.33 [49.98–107.50]
|
0.372
|
|
sIGFBP-7, ng/mL
|
107.92 [87.47–125.02]
|
108.17 [83.65–135.71]
|
125.26 [103.07–148.35]
|
0.255
|
|
sCysC, mg/L
|
0.60 [0.47–0.78]
|
0.73 [0.54–0.96]
|
1.10 [1.06–1.72]*#
|
< 0.001
|
|
uFGF23, pg/mg uCr
|
74.40 [39.20–225.8]
|
47.14 [28.82–130.6]
|
172.93 [114.37–448.25]*#
|
0.033
|
|
uIGFBP-7, ng/mg uCr
|
291.57 [135.60–539.04]
|
244.33 [87.51–478.73]
|
653.50 [301.94–2072.06]*#
|
0.005
|
|
uCysC, ng/mg uCr
|
183.17 [94.62–494.96]
|
122.38 [80.27–332.97]
|
6559.79 [1224.42–30,414.64]*#
|
< 0.001
|
- Values are median [interquartile range]
- AKI network stage 1 was defined as mild AKI, and AKIN stages 2 and 3 were defined as severe AKI
- *P < 0.05, compared with non-AKI; #P < 0.05, compared with mild AKI
